Published in Ann Hematol on February 04, 1998
Predictors of anaemia and iron deficiency in HIV-infected pregnant women in Tanzania: a potential role for vitamin D and parasitic infections. Public Health Nutr (2011) 1.74
Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr (2009) 1.69
Plasma folate studies in HIV-positive patients at the Lagos university teaching hospital, Nigeria. Indian J Sex Transm Dis (2010) 1.44
Neonatal erythropoiesis and subsequent anemia in HIV-positive and HIV-negative Zimbabwean babies during the first year of life: a longitudinal study. BMC Infect Dis (2006) 1.06
Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia. BMC Infect Dis (2011) 1.03
Morbidity and Mortality Patterns of Hospitalised Adult HIV/AIDS Patients in the Era of Highly Active Antiretroviral Therapy: A 4-year Retrospective Review from Zaria, Northern Nigeria. AIDS Res Treat (2012) 1.00
Anaemia in HIV-infected children: severity, types and effect on response to HAART. BMC Pediatr (2012) 0.97
Prevalence, severity, and related factors of anemia in HIV/AIDS patients. J Res Med Sci (2012) 0.96
Anaemia in acute HIV-1 subtype C infection. PLoS One (2008) 0.96
Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections. Proc Natl Acad Sci U S A (2014) 0.91
Prevalence and related factors of anemia in HAART-naive HIV positive patients at Gondar University Hospital, Northwest Ethiopia. BMC Hematol (2013) 0.88
Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. World J Virol (2013) 0.88
The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from Mwanza, Tanzania. BMC Infect Dis (2012) 0.85
The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children. J Int AIDS Soc (2015) 0.79
Magnitude of Anemia and Associated Factors among Pediatric HIV/AIDS Patients Attending Zewditu Memorial Hospital ART Clinic, Addis Ababa, Ethiopia. Anemia (2015) 0.76
Prevalence and associated risk factors of anemia among HIV infected children attending Gondar university hospital, Northwest Ethiopia: a cross sectional study. BMC Hematol (2015) 0.76
Anemia, diet and therapeutic iron among children living with HIV: a prospective cohort study. BMC Pediatr (2015) 0.76
Determinants of Anemia Among Human Immunodeficiency Virus-Positive Adults at Care and Treatment Clinics in Dar es Salaam, Tanzania. Am J Trop Med Hyg (2015) 0.75
Getting to 90-90-90 in paediatric HIV: What is needed? J Int AIDS Soc (2015) 0.75
Profile of blood cell abnormalities among antiretroviral therapy naïve HIV patients attending the Yaounde University Teaching Hospital, Cameroon. BMC Hematol (2014) 0.75
Causes of death and factors associated with early mortality of HIV-infected adults admitted to Korle-Bu Teaching Hospital. Pan Afr Med J (2017) 0.75
Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet (2005) 3.97
Late presentation of HIV infection: a consensus definition. HIV Med (2011) 2.67
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91
[Fatty liver and increased serum lactate in a woman with HIV]. Dtsch Med Wochenschr (2003) 1.44
Mixed-strain infection with a drug-sensitive and multidrug-resistant strain of Mycobacterium tuberculosis. Lancet (1995) 1.32
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA. HIV Med (2013) 1.28
CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions--review of the literature. Eur J Med Res (2007) 1.10
When is discontinuation of antihypertensive therapy indicated? Cardiovasc Drugs Ther (1990) 1.10
Malignant thymoma: current status of classification and multimodality treatment. Ann Hematol (2003) 1.09
Influence of protease inhibitor therapy on lipoprotein metabolism. J Intern Med (1999) 1.08
Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases. J Viral Hepat (2005) 1.07
Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study. Eur J Clin Invest (1998) 1.02
Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection. Eur J Clin Nutr (1997) 1.01
T(H)1 to T(H)2 shift of cytokines in peripheral blood of HIV-infected patients is detectable by reverse transcriptase polymerase chain reaction but not by enzyme-linked immunosorbent assay under nonstimulated conditions. J Acquir Immune Defic Syndr (2000) 1.00
Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res (1997) 0.97
Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal. J Hepatol (1998) 0.97
Inadequate erythropoietin response to anaemia in HIV patients: relationship to serum levels of tumour necrosis factor-alpha, interleukin-6 and their soluble receptors. Br J Haematol (1997) 0.96
Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real-time PCR using multi-specific standards. J Immunol Methods (2000) 0.92
The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II. Clin Exp Immunol (1997) 0.91
Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence. Eur J Med Res (2011) 0.91
Is stage conversion the initiating event for reactivation of Toxoplasma gondii in brain tissue of AIDS patients? J Parasitol (2000) 0.91
Prediction of imminent complications in HIV-1-infected patients by markers of lymphocyte apoptosis. J Acquir Immune Defic Syndr (2000) 0.90
Decreased prevalence of Helicobacter pylori infection in HIV patients with AIDS defining diseases. Z Gastroenterol (2002) 0.90
Is the increase in serum cystathionine levels in patients with liver cirrhosis a consequence of impaired homocysteine transsulfuration at the level of gamma-cystathionase? Scand J Gastroenterol (2000) 0.89
Treatment results of chronic hepatitis C genotype 5 and 6 infections in Germany. Z Gastroenterol (2012) 0.89
Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: description of a new case and review of the literature. Infection (2013) 0.88
[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005]. Dtsch Med Wochenschr (2007) 0.88
Progression of liver fibrosis in HIV/HCV genotype 1 co-infected patients is related to the T allele of the rs12979860 polymorphism of the IL28B gene. Eur J Med Res (2011) 0.88
Lymphoid pneumonitis as an immune reconstitution inflammatory syndrome in a patient with CD4 cell recovery after HAART initiation. HIV Med (2006) 0.88
Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med (2015) 0.87
Superior virological efficacy of ritonavir-boosted protease inhibitor regimens compared to single protease inhibitor therapy. Eur J Med Res (2003) 0.87
Semiquantitation of human chemokine mRNA levels with a newly constructed multispecific competitor fragment. J Immunol Methods (1999) 0.85
Causes of death in HIV-infected patients from the Cologne-Bonn cohort. Infection (2013) 0.84
Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy. HIV Med (2013) 0.84
Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients. AIDS (1999) 0.83
Role of HIV-1 phenotype in viral pathogenesis and its relation to viral load and CD4+ T-cell count. J Med Virol (1998) 0.83
First-line ritonavir/indinavir 100/800 mg twice daily plus nucleoside reverse transcriptase inhibitors in a German multicentre study: 48-week results. HIV Med (2002) 0.82
Predicting in-hospital outcome in HIV-associated Pneumocystis carinii pneumonia. Infection (1996) 0.82
Decrease of elevated N,N-dimethylglycine and N-methylglycine in human immunodeficiency virus infection during short-term highly active antiretroviral therapy. Metabolism (2001) 0.82
Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery. Infection (2005) 0.82
Protection against parenteral HIV-1 infection by homozygous deletion in the C-C chemokine receptor 5 gene. AIDS (1999) 0.82
Primary drug-resistance in HIV-positive patients on initiation of first-line antiretroviral therapy in Germany. Eur J Med Res (2004) 0.81
Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance. HIV Med (2014) 0.81
Effect of fusidic acid on the hepatic cytochrome P450 enzyme system. Int J Clin Pharmacol Ther (1999) 0.81
Antihypertensive therapy. To stop or not to stop? JAMA (1991) 0.81
HCV/HIV-coinfection--is there a state of the art after APRICOT and RIBAVIC? J Antimicrob Chemother (2005) 0.81
Splenic abscesses and abdominal tuberculosis in patients with AIDS. Z Gastroenterol (1996) 0.80
A prospective, controlled study assessing the effect of lopinavir on amprenavir concentrations boosted by ritonavir. HIV Med (2004) 0.80
Plasma antioxidant capacity of HIV-seropositive and healthy subjects during long-term ingestion of fruit juices or a fruit-vegetable-concentrate containing antioxidant polyphenols. Eur J Clin Nutr (2001) 0.80
Pharmacokinetics of the combination raltegravir/atazanavir in HIV-1-infected patients. HIV Med (2013) 0.79
Cytokine profile of HIV-positive Kaposi's sarcoma derived cells in vitro. Eur J Med Res (1999) 0.79
Parallel decrease in neurotoxin quinolinic acid and soluble tumor necrosis factor receptor p75 in serum during highly active antiretroviral therapy of HIV type 1 disease. AIDS Res Hum Retroviruses (2000) 0.79
The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals. Eur J Med Res (2010) 0.79
Hepatitis C in the patient with human immunodeficiency virus infection. J Hepatol (1998) 0.79
Screening colonoscopy in HIV-infected patients: high rates of mucosal abnormalities in a German HIV-infected cohort. HIV Med (2013) 0.79
High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance. HIV Med (2014) 0.79
[Progressive multifocal leukoencephalopathy]. Med Klin (Munich) (1999) 0.77
Orthotopic liver transplantation in human-immunodeficiency-virus-positive patients in Germany. AIDS Res Treat (2012) 0.77
[Therapy of hepatitis B and hepatitis C coinfection in HIV patients]. MMW Fortschr Med (2005) 0.77
Changes of lymphocyte apoptosis associated with sequential introduction of highly active antiretroviral therapy. HIV Med (2003) 0.77
How will we manage acute HCV in men having sex with men in the era of all oral therapy? J Viral Hepat (2014) 0.77
Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs. AIDS (1998) 0.77
Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients. J Viral Hepat (2014) 0.77
Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicity. Eur J Clin Pharmacol (2007) 0.77
[Cardiac manifestations in advanced HIV infection]. Dtsch Med Wochenschr (1994) 0.77
Discontinuation of antihypertensive therapy: prevalence of relapses and predictors of successful withdrawal in a hypertensive community. Cardiology (1997) 0.76
[Morbidity and mortality in HIV infection]. Internist (Berl) (2012) 0.76
Effect of long-term primary aerosolized pentamidine prophylaxis on breakthrough Pneumocystis carinii pneumonia. Eur Respir J (1996) 0.76
Gender-specific cardiovascular adaptation due to circadian blood pressure variations in essential hypertension. Am J Hypertens (1995) 0.76
Fatal pneumonia in an AIDS patient coinfected with adenovirus and Pneumocystis carinii. Infection (2000) 0.76
A comparative study of different enzyme immunosorbent assays for human tumor necrosis factor-alpha. J Immunol Methods (1996) 0.76
The probability of acquiring primary Toxoplasma infection in HIV-infected patients: results of an 8-year retrospective study. Infection (1998) 0.75
Management of progressive outer retinal necrosis with cidofovir in a human immunodeficiency virus-infected patient. Clin Infect Dis (1999) 0.75
Transmission of human immunodeficiency virus I drug resistance - a case report. What are the clinical implications? Eur J Med Res (2010) 0.75
Nephrogenic diabetes insipidus in a patient taking cidofovir. Lancet (1997) 0.75
[Do polymorphisms of the SDF1 and CCR2b genes modify the course of hepatitis C or HIV/HCV co-infection?]. Dtsch Med Wochenschr (2002) 0.75
[HIV and hepatitis coinfection]. Dtsch Med Wochenschr (2005) 0.75
Comparison of early target organ damage between blacks and whites with mild systemic arterial hypertension. Am J Cardiol (1997) 0.75
[Intensive therapy of acute respiratory insufficiency in HIV infected patients. Current decision guidelines and therapy options]. Pneumologie (1997) 0.75
Enteric dysfunction in patients with asymptomatic HIV-infection versus patients with hypoproteinemia/hypalbuminemia and advanced HIV-infection. Eur J Med Res (2002) 0.75
[HIV-associated cholangiopathy]. Dtsch Med Wochenschr (1994) 0.75
Lymphocyte proliferation and apoptosis in HIV-seropositive and healthy subjects during long-term ingestion of fruit juices or a fruit-vegetable-concentrate rich in polyphenols and antioxidant vitamins. Eur J Clin Nutr (2004) 0.75
Pneumocystis carinii pneumonia in the Federal Republic of Germany in the era of changing antiretroviral therapy - IDKF 13 -. German AIDS Study Group (GASG/IdKF). Eur J Med Res (1999) 0.75
[HIV-associated Pneumocystis carinii pneumonia, primary pentamidine inhalation prophylaxis notwithstanding. Are there differences with Pneumocystis carinii pneumonia without prophylaxis?]. Dtsch Med Wochenschr (1996) 0.75
Painful multifocal arthritis: therapy with rhenium 186 hydroxyethylidenediphosphonate ((186)Re HEDP) after failed treatment with medication--initial results of a prospective study. Radiology (2001) 0.75
New aspects in the treatment of AIDS-related lymphoma. Eur J Med Res (2002) 0.75
Changing role of invasive aspergillosis in AIDS--a case control study. J Infect (1998) 0.75
[Orthotopic liver transplantation in a 33-year-old patient with fulminant hepatitis B and HIV infection]. Dtsch Med Wochenschr (2000) 0.75
[Mycobacterium avium infection presenting as a mass in the right lung]. Med Klin (Munich) (2000) 0.75
[Nucleoside induced hepatopathy in HIV patients. Diagnostic value of liver biopsy assessment]. Pathologe (2004) 0.75
Obesity and hypertension. Curr Opin Nephrol Hypertens (1994) 0.75
Elevated serum activity of N-acetyl-beta-glucosaminidase in essential hypertension: diagnostic value and reversal to normal values after antihypertensive therapy. Am J Kidney Dis (1991) 0.75
[Improved prognosis of first episode HIV associated Pneumocystis carinii pneumonia without preventive treatment: etiology and sequelae]. Pneumologie (1996) 0.75
Efficacy and tolerance of low-dose loop diuretics in hypertension. Cardiology (1994) 0.75
Endogenous levels of C-C chemokines MIP-1alpha, MIP-1beta, and RANTES do not reflect the disease course in HIV-seropositive individuals. Int J Clin Lab Res (2000) 0.75